Pathology at Johns Hopkins

The Department of Pathology at Johns Hopkins is preeminent nationally and globally in the study and treatment of human disease and in professional training in all areas of pathology and laboratory science. Currently, there are over 1400 people in the department, which includes approximately 120 full-time faculty, 36 residents, 45 graduate students, over 100 fellows, and 1000 staff members.

Grand Rounds



Pathobiology Thesis Seminar

Monday, March 20, 2017
Role of Cytochrome P450 Enzymes in the Acute Myeloid Leukemia Bone Marrow Microenvironment
Speaker: Meng Su
Time: 4:00 pm
Place: CRB I, Rm. 3M42
Advisor: Dr. Richard Jones


Learn more about our Pathobiology Program »

Department Blog

Loading Blog Feeds

All Pathology blogs >>

What's New?

Interview with Dr. Kathleen Gabrielson

February 21, 2017

Dr. Kurman and Dr. Shih
Dr. Kathleen Gabrielson talked about her current research regarding the toxic effects of stress on the body. Read full interview.



Hopkins Tops NIH Funding for FY 2016

February 16, 2017

The Blue Ridge Institute for Medical Research just released the 2016 NIH funding numbers, and our department once again tops the list as the #1 funded pathology department! This continues a remarkable streak in which we have been the #1 funded pathology department for 9 of the last 10 years! Four of the top 25 most highly funded pathology investigators are from Hopkins (congratulations Drs. Nachman, S. Eshleman, TC Wu and D. Chan!). Most importantly, the broad and deep science in our department has real impact - it advances knowledge and helps fight human suffering.

From the BLUE RIDGE INSTITUTE for MEDICAL RESEARCH:

RankNamePathology
1 Johns Hopkins University$43,832,245
2 University of Pennsylvania$37,262,718
3 Emory University$34,460,238
4 Washington University$29,807,683
5 Columbia University Health Sciences$25,815,633

Click here to view the full list in Pathology.
To see the Ranking Tables of NIH Funding to US Medical Schools in 2016, click here.


Congratulations, Ovarian Cancer Research Team!

February 6, 2017

Richard Roden, PhD, Tian-Li Wang, PhD, and Ie-Ming Shih, MD, PhD
Richard Roden, Ph.D., Tian-Li Wang, Ph.D., and Ie-Ming Shih, M.D., Ph.D., have received the Ovarian Cancer Research Fund Alliance Collaborative Research Development Grant. This award will help the team's research to test new and various treatment strategies for ovarian cancer. Read more



All Pathology News >>